Autres langues Cellnovo

Actions

CLNV

FR0012633360

Logiciels

Temps réel Euronext Paris			Varia. 5j.	Varia. 1 janv.
- ^EUR	-.--%		-.--%	-

10/05/19	En Direct des Marchés : Kering, Total, Air France, LafargeHolcim, Sopra, Cellnovo, Uber, Facebook...
10/05/19	Droits de douane à 25%, Washington met sa menace à exécution

Autres langues

28/03/19	Cellnovo Group Stops Manufacturing and Commercial Operations
26/03/19	Cellnovo : announces the initiation of collective proceedings regarding its UK subsidiary and requests the opening of conciliation proceedings in France
21/03/19	Cellnovo Group Sa Provides Revenue Guidance for the First Quarter of 2019
18/02/19	Cellnovo Group SA Announces Expands its Base of Potential Users
06/02/19	Cellnovo Group Launches New Mobile Application Connected to Continuous Glucose Monitoring Data Via HealthKit
29/01/19	Cellnovo Group SA announced that it has received €1.5 million in funding from Yorkville Advisors Global LP
15/01/19	Cellnovo Group Announces Sales Results for the Fourth Quarter and Full Year of 2018
14/01/19	Cellnovo : Drawing of a second tranche of financing from Kreos Capital. Revision of the terms and conditions of the funding agreement
14/01/19	Cellnovo Group Announces the Drawing of Second Tranche of Financing of €3 Million from Kreos Capital
14/01/19	Cellnovo Group SA announced that it expects to receive €1.5 million in funding from Yorkville Advisors Global LP
03/12/18	Cellnovo and ForaCare Signs an Agreement to Connect ForaCare’s Glucose Monitoring Device to the Cellnovo Gen 3 System
28/11/18	Cellnovo Group SA Signs New Collaboration to Allow for Automatic Data Transfer from Roche’s Accu-Chek Bluetooth-Enabled Blood Glucose Meters to the Cellnovo Gen 3 System
29/10/18	Cellnovo Group Announces Distribution Agreement in Colombia with Diabetrics
11/10/18	Cellnovo Group Announces Sales Results for the Third Quarter and Nine Months Ended September 30, 2018
05/09/18	Cellnovo Group Announces Launch of its Gen 3 System
26/07/18	Cellnovo Group Announces Sales Results for the Second Quarter and Earnings Results for the Half Year Ended June 30, 2018
26/07/18	Cellnovo Group SA announced that it expects to receive €3 million in funding from Kreos Capital
29/05/18	Cellnovo Limited Elects Pierre Chancel as A Board Member
11/04/18	Cellnovo Group Reports Earnings Results for the Year Ended December 31, 2017; Reports Sales Results for the First Quarter Ended March 31, 2018
14/02/18	Cellnovo Group Updates on Results of Cellnovo’s Diabetes Management System
17/01/18	Cellnovo Group Announces Sales Results for the Fourth Quarter and Full Year Ended December 31, 2017
14/12/17	Cellnovo Group Announces the Launch of the First Clinical Study in the EU-Funded PEPPER Project
13/12/17	Cellnovo : announces the CE marking of the first Bluetooth and Android-enabled micro-pump for insulin delivery
13/12/17	Cellnovo Announces the CE Marking of the First Bluetooth and Android-Enabled Micro-Pump for Insulin Delivery
03/11/17	Cellnovo Provides an Update on Its Partnership with Diabeloop for the Development of an Artificial Pancreas Solution